# US 2020/0123593 A1 · Systems and methods for sample preparation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0123593 A1
- Document ID: US20200123593A1
- Status: Published application
- Kind: A1
- Application number: 16/667,273
- Filed: 2019-10-29
- Published: 2020-04-23
- Earliest claimed: 2011-05-20
- Assignees: Quantum-Si Incorporated
- Applicants: Quantum-Si Incorporated
- Inventors: Jonathan M. Rothberg; John H. Leamon; Jonathan C. Schultz; Michele Millham; Cassie Lv; Xiaxiao Ma
- Web page: https://patentgrep.com/patent/US20200123593A1

## CPC

- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- B03C 7/023: {Non-uniform field separators}
- C12N 15/1003: {Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor}
- C12N 15/101: {by chromatography, e.g. electrophoresis, ion-exchange, reverse phase}
- C12Q 1/6837: using probe arrays or probe chips (C12Q1/6874 takes precedence)
- G01N 33/5308: {for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites}
- G01N 33/543: with an insoluble carrier for immobilising immunochemicals
- G01N 33/54366: {Apparatus specially adapted for solid-phase testing}
- G01N 33/575: for cancer
- G01N 33/689: {related to pregnancy or the gonads}
- G01N 2800/385: Congenital anomalies
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- B03C: MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS (separating isotopes B01D59/00; combinations of magnetic or electrostatic separation with separation of solids by other means B03B, B07B)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Methods and devices for isolating or enriching target molecules from a sample are provided herein. In some embodiments, methods and devices further involve detection, analysis and/or sequencing of a target molecule.

## Claims

### Claim 1

A device for enriching a target molecule from a biological sample, the device comprising an automated sample preparation module comprising a cartridge housing that is configured to receive a removable cartridge.

### Claim 2 (depends on 1)

The device of claim 1, wherein the removable cartridge is a single-use cartridge or a multi-use cartridge.

### Claim at position 3

-4. (canceled)

### Claim 5 (depends on 1)

The device of claim 1, wherein the cartridge comprises one or more microfluidic channels configured to contain and/or transport a fluid used in a sample preparation process.

### Claim 6 (depends on 1)

The device of claim 1, wherein the cartridge comprises one or more affinity matrices, wherein each affinity matrix comprises an immobilized capture probe that has a binding affinity for the target molecule.

### Claim 7 (depends on 1)

The device of claim 1, wherein the biological sample is a blood, saliva, sputum, feces, urine or buccal swab sample.

### Claim 8 (depends on 1)

The device of claim 1, wherein the target molecule is a target nucleic acid.

### Claim 9

(canceled)

### Claim 10 (depends on 6)

The device of claim 6, wherein the immobilized capture probe is an oligonucleotide capture probe, and wherein the oligonucleotide capture probe comprises a sequence that is at least partially complementary to the target nucleic acid.

### Claim 11 (depends on 10)

The device of claim 10, wherein the oligonucleotide capture probe comprises a sequence that is at least 80%, 90% 95%, or 100% complementary to the target nucleic acid.

### Claim 12 (depends on 8)

The device of claim 8, wherein the device produces target nucleic acid with an average read-length for downstream sequencing applications that is longer than an average read-length produced using control methods.

### Claim 13 (depends on 1)

The device of claim 1, wherein the target molecule is a target protein.

### Claim 14 (depends on 13)

The device of claim 13, wherein the immobilized capture probe is a protein capture probe that binds to the target protein, optionally wherein the protein capture probe is an aptamer or an antibody.

### Claim at position 14

-16. (canceled)

### Claim 17 (depends on 1)

The device of claim 1, wherein the device further comprises a sequencing module.

### Claim at position 16

-19. (canceled)

### Claim 20 (depends on 17)

The device of claim 17, wherein the sequencing module performs nucleic acid sequencing, optionally wherein the nucleic acid sequencing comprises single-molecule real-time sequencing, sequencing by synthesis, sequencing by ligation, nanopore sequencing, and/or Sanger sequencing.

### Claim 21

(canceled)

### Claim 22 (depends on 17)

The device of claim 17, wherein the sequencing module performs polypeptide sequencing or single-molecule polypeptide sequencing.

### Claim at position 20

-24. (canceled)

### Claim 25

A method for purifying a target molecule from a biological sample, the method comprising:
(i) lysing the biological sample;
(ii) fragmenting the lysed sample of (i); and
(iii) enriching the sample using an affinity matrix comprising an immobilized capture probe that has a binding affinity for the target molecule
thereby purifying the target molecule, wherein the target molecule is a target nucleic acid or a target protein.

### Claim at position 22

-45. (canceled)

### Claim 46

A device for enriching a target molecule from a biological sample, the device comprising an automated sample preparation module, wherein the automated sample preparation module performs the following steps:
(i) receives a biological sample
(ii) lyses the biological sample;
(iii) fragments the sample of (ii); and
(iv) enriches the sample using an affinity matrix comprising an immobilized capture probe that has a binding affinity for the target molecule.

### Claim 47 (depends on 46)

The device of claim 46, wherein the target molecule is a molecule is a target nucleic acid.

### Claim 48

(canceled)

### Claim 49 (depends on 47)

The device of claim 47, wherein the immobilized capture probe is an oligonucleotide capture probe, and wherein the oligonucleotide capture probe comprises a sequence that is at least partially complementary to the target nucleic acid.

### Claim 50 (depends on 49)

The device of claim 49, wherein the oligonucleotide capture probe comprises a sequence that is at least 80%, 90% 95%, or 100% complementary to the target nucleic acid.

### Claim 51 (depends on 46)

The device of claim 46, wherein the target molecule is a target protein.

### Claim 52 (depends on 51)

The device of claim 51, wherein the immobilized capture probe is a protein capture probe that binds to the target protein optionally wherein the protein capture probe is an aptamer or an antibody.

### Claim at position 30

-54. (canceled)

### Claim 55 (depends on 46)

The device of claim 46, wherein the device further comprises a sequencing module.

### Claim at position 32

-57. (canceled)

### Claim 58 (depends on 55)

The device of claim 55, wherein the sequencing module performs nucleic acid sequencing or polypeptide sequencing.

### Claim at position 34

-63. (canceled)
